Switch to:

Dova Pharmaceuticals EV-to-EBITDA

: -10.80 (As of Today)
View and export this data going back to 2017. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dova Pharmaceuticals's enterprise value is $771.45 Mil. Dova Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was $-71.43 Mil. Therefore, Dova Pharmaceuticals's EV-to-EBITDA for today is -10.80.

NAS:DOVA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.4   Med: -5.6   Max: -1.5
Current: -10.8

-15.4
-1.5

During the past 3 years, the highest EV-to-EBITDA of Dova Pharmaceuticals was -1.50. The lowest was -15.40. And the median was -5.60.

NAS:DOVA's EV-to-EBITDA is not ranked
in the Biotechnology industry.

( Industry Median: 30.22 vs. NAS:DOVA: -10.80 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-09-24), Dova Pharmaceuticals's stock price is $28.04. Dova Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.61. Therefore, Dova Pharmaceuticals's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Dova Pharmaceuticals EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Dova Pharmaceuticals Annual Data
Dec16 Dec17 Dec18
EV-to-EBITDA 0.00 -23.48 -1.84

Dova Pharmaceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.09 -1.84 -2.49 -5.01 -10.77

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Dova Pharmaceuticals EV-to-EBITDA Distribution

* The bar in red indicates where Dova Pharmaceuticals's EV-to-EBITDA falls into.



Dova Pharmaceuticals EV-to-EBITDA Calculation

Dova Pharmaceuticals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=771.450/-71.425
=-10.80

Dova Pharmaceuticals's current Enterprise Value is $771.45 Mil.
Dova Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was -18.759 (Dec. 2018 ) + -15.796 (Mar. 2019 ) + -16.471 (Jun. 2019 ) + -20.399 (Sep. 2019 ) = $-71.43 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Dova Pharmaceuticals  (NAS:DOVA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Dova Pharmaceuticals's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28.04/-2.61
=

Dova Pharmaceuticals's share price for today is $28.04.
Dova Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was -0.69 (Dec. 2018 ) + -0.58 (Mar. 2019 ) + -0.6 (Jun. 2019 ) + -0.74 (Sep. 2019 ) = $-2.61.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Dova Pharmaceuticals EV-to-EBITDA Related Terms


Dova Pharmaceuticals EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)